CDER PLANS TO HIRE ADDITIONAL 160 FTEs DEDICATED TO DRUG REVIEW
CDER PLANS TO HIRE ADDITIONAL 160 FTEs DEDICATED TO DRUG REVIEW during fiscal year 1994. FDA's Center for Drug Evaluation & Research has set a goal to bring on board 160 additional full-time equivalents above its FY 1993 base of 823 FTEs involved in the application review process. Accounting for attrition, CDER estimates that with the "user fee hires" it will gain a total of 75 FTEs.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth